rTMS treatment
Device1 Hz rTMS
NCT Number: NCT04934007
According to the literature the lateral part of the Orbito Frontal Cortex (lOFC) is a relevant bilateral target for repetitive Trans-cranial Magnetic Stimulation (rTMS) in Obsessive Compulsive Disorder (OCD). Both hemispheres are concerned in terms of target.
Interested in participating?
Request Info18 year–65 year
All sexes
Interventional
Not applicable
Sorbonne University, Pitié-Salpêtrière Hospital, Paris, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
1 Hz rTMS
Time frame: baseline and 25 days
Significant clinical change (≥ 25%) from baseline to two weeks after the treatment sequence, assessed by a significant reduction in YBOCS scores at day 25
Time frame: baseline and 70 days
Significant clinical change of the YBOCS score (≥25% decrease), from baseline to day 70
Time frame: baseline and 25 days
Change of the general assessement functioning (GAF) at day 25
Time frame: baseline and 70 days
Change of the general assessement functioning (GAF) at day 70
Time frame: baseline and 25 days
Clinical Global Impressions (CGI) change at day 25
Time frame: baseline and 70 days
Clinical Global Impressions (CGI) change at day 70
Time frame: 70 days
Number and types of adverse events linked to the rTMS treatment
Contact information is provided by the study sponsor or research team.
Ghina Harika-Germaneau, MD, PhD
CONTACT
Nematollah Jaafari, PR
CONTACT
Centre Hospitalier Henri Laborit
Other
A Randomized Control Trial of Bilateral Lateral OFC rTMS in Obsessive Compulsive Disorder
Acronym: ORBITOC3
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07347405
Anxiety Disorders, Mental Disorders
Tucson, Arizona, United States
View Trial DetailsNCT07701616
Anxiety Disorders, Mental Disorders
Changsha, Hunan, China
View Trial DetailsNCT06376734
Anxiety Disorders, Behavior
Sunnyvale, California, United States
View Trial DetailsNCT07704632
Anxiety Disorders, Mental Disorders
Toronto, Ontario, Canada
View Trial Details